Gilead Sciences | 자산

Assets 변화 날짜
AbbVie USD 136.22B 854M 2023-09
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Incyte USD 6.78B 393.87M 2023-12
Merck USD 106.73B 2.26B 2023-09
Moderna USD 18.43B 1.02B 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
United Therapeutics USD 7.17B 143.4M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Gilead Sciences 자산 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.